ARVN Competitors & Alternatives
Compare Arvinas Inc with similar stocks in the same industry
Biotechnology
ARVN
Main Stock$8.39
Tradestie Score
51
Market Cap
$670.30M
Revenue Growth
-0.9%
Analyst Upside
+76.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.82
|
$552.46M | - | 58 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$15.23
|
$540.97M | - | 55 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.69
|
$533.99M | - | 55 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.98
|
$529.35M | 6.9 | 62 | Compare |
|
OCGN
Ocugen, Inc. Common Stock
|
$1.51
|
$524.67M | - | 57 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$97.79
|
$522.78M | - | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.32
|
$512.39M | - | 59 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$38.72
|
$505.12M | 2.0 | 54 | Compare |
|
RGNX
REGENXBIO Inc.
|
$13.28
|
$493.52M | - | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.58
|
$492.21M | - | 52 | Compare |
More ARVN Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry